LPL Financial
CSTL icon

LPL Financial’s Castle Biosciences CSTL Stock Holding History

LPL Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
14,220
+4,520
+47% +$101K ﹤0.01% 5349
2026
Q1 		$238K Sell
9,700
-1,177
-11% -$38.5K ﹤0.01% 5365
2025
Q4 		$423K Buy
10,877
+1,480
+16% +$47.7K ﹤0.01% 4868
2025
Q3 		$214K Buy
+9,397
New +$191K ﹤0.01% 5299
2025
Q1 		– Sell
-23,043
Closed -$614K – 5392
2024
Q4 		$614K Sell
23,043
-3,421
-13% -$104K ﹤0.01% 3913
2024
Q3 		$755K Buy
+26,464
New +$674K ﹤0.01% 3657

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's CSTL Position: Q2 2026 in Review

LPL Financial increased its Castle Biosciences (CSTL) stake by 47% in Q2 2026, buying an estimated $101K and bringing the position to 14,220 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #5349.

LPL Financial first reported a position in CSTL in Q3 2024 and has held it in 6 quarters since. The position peaked at $755K in Q3 2024. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • LPL Financial held 14,220 shares of Castle Biosciences worth $339K as of Q2 2026.
  • LPL Financial bought 4,520 Castle Biosciences shares in Q2 2026, an estimated $101K.
  • Castle Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5349 holding.
  • LPL Financial first reported a position in Castle Biosciences in Q3 2024 and has held it in 6 quarters since.
  • LPL Financial's Castle Biosciences position peaked at $755K in Q3 2024.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.